Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1519701
PUBLISHER: IMARC | PRODUCT CODE: 1519701
Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2024-2032
PUBLISHED:
PAGES: 147 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global narcolepsy drugs market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.99% during 2024-2032.
Narcolepsy drugs refer to pharmaceutical medicines used for the treatment of chronic sleep disorders. The disorder is characterized by excessive daytime sleepiness (EDS), cataplexy or sudden loss of muscle strength, sleep paralysis, hallucinations, fragmented sleep and insomnia. Additional symptoms may include automatic behaviors without conscious awareness, blurred vision, double vision or droopy eyelids and disturbed mental functioning. Patients suffering from narcolepsy tend to sleep the same number of hours per day as normal individuals; however, sleep quality tends to be poorer. Some of the commonly used narcolepsy drugs include central nervous system stimulants, sodium oxybate, selective serotonin reuptake inhibitors and tricyclic antidepressants. These drugs aid in improving wakefulness in adult patients and minimizing hallucinations, sleepiness and cataplexy.
Narcolepsy Drugs Market Trends:
The increasing prevalence of narcolepsy across the globe is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the working population, which, in turn, is significantly increasing the incidences of sleep-related disorders. Moreover, rising health consciousness among the masses and the increasing awareness regarding the available treatment alternatives are providing a thrust to the market growth. In line with this, the widespread adoption of sodium oxybate for the treatment of narcolepsy in children is also contributing to the growth of the market. Additionally, significant improvements in the diagnostic technologies for narcolepsy are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing variants with long-term benefits and reduced side effects. Other factors, including the rising geriatric population, which is more susceptible to such ailments, along with extensive research and development (R&D) activities in the field of neurology, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global narcolepsy drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, disease type and therapeutic type.
Breakup by Type:
Narcolepsy with Cataplexy
Narcolepsy without Cataplexy
Secondary Narcolepsy
Breakup by Disease Type:
Daytime Extreme Sleepiness
Cataplexia
Others
Breakup by Therapeutic Type:
Sodium Oxybate
Central Nervous System Stimulants
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitor
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
- How has the global narcolepsy drugs market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global narcolepsy drugs market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the disease type?
- What is the breakup of the market based on the therapeutic type?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global narcolepsy drugs market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A5685
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Narcolepsy Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Narcolepsy with Cataplexy
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Narcolepsy without Cataplexy
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Secondary Narcolepsy
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Disease Type
- 7.1 Daytime Extreme Sleepiness
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cataplexia
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Therapeutic Type
- 8.1 Sodium Oxybate
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Central Nervous System Stimulants
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Tricyclic Antidepressants
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Selective Serotonin Reuptake Inhibitor
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Avadel Pharmaceuticals plc
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Axsome Therapeutics Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 Bioprojet Pharma
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Graymark Healthcare Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Jazz Pharmaceuticals plc
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Ligand Pharmaceuticals Incorporated
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Novartis AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 SHIONOGI & Co. Ltd.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Takeda Pharmaceutical Company Limited
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Teva Pharmaceutical Industries Ltd.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Avadel Pharmaceuticals plc
Product Code: SR112024A5685
List of Figures
- Figure 1: Global: Narcolepsy Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Narcolepsy Drugs Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Narcolepsy Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Narcolepsy Drugs Market: Breakup by Type (in %), 2023
- Figure 5: Global: Narcolepsy Drugs Market: Breakup by Disease Type (in %), 2023
- Figure 6: Global: Narcolepsy Drugs Market: Breakup by Therapeutic Type (in %), 2023
- Figure 7: Global: Narcolepsy Drugs Market: Breakup by Region (in %), 2023
- Figure 8: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Narcolepsy Drugs (Cataplexia) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Narcolepsy Drugs (Cataplexia) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Narcolepsy Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Narcolepsy Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Narcolepsy Drugs (Sodium Oxybate) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Narcolepsy Drugs (Sodium Oxybate) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Narcolepsy Drugs (Other Therapeutic Types) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Narcolepsy Drugs (Other Therapeutic Types) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: North America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: North America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: United States: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: United States: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Canada: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Canada: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Asia-Pacific: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Asia-Pacific: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: China: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: China: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Japan: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Japan: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: India: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: India: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: South Korea: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: South Korea: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Australia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Australia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Indonesia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Indonesia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Europe: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Europe: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Germany: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Germany: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: France: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: France: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: United Kingdom: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: United Kingdom: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Italy: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Italy: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Spain: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Spain: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Russia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Russia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Latin America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Latin America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Brazil: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Brazil: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Mexico: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Mexico: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Middle East and Africa: Narcolepsy Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Middle East and Africa: Narcolepsy Drugs Market: Breakup by Country (in %), 2023
- Figure 78: Middle East and Africa: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Global: Narcolepsy Drugs Industry: SWOT Analysis
- Figure 80: Global: Narcolepsy Drugs Industry: Value Chain Analysis
- Figure 81: Global: Narcolepsy Drugs Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Narcolepsy Drugs Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Narcolepsy Drugs Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Narcolepsy Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
- Table 4: Global: Narcolepsy Drugs Market Forecast: Breakup by Therapeutic Type (in Million US$), 2024-2032
- Table 5: Global: Narcolepsy Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Narcolepsy Drugs Market: Competitive Structure
- Table 7: Global: Narcolepsy Drugs Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.